drugset / Trial / NCT05677763
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.
Timeline
- Start
- 2022-12-12
- Primary completion
- 2026-03-10
- Completion
- 2026-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Broncho-Vaxom | Other / unclassified | 3.5 mg | Oral |